Search - tctmd.com

Displaying 501 - 520 of 671

Sort: Relevancy | Date

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

October 12, 2012

News Daily News

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

September 27, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

Presentation

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Presenter: 56196|JY Kim

September 14, 2012

Presentation

Association of Clopidogrel Treatment with Risk of Mortality and Cardiovascular Events Following MI in Patients With and Without Diabetes

Presenter: Charlotte Andersson

September 06, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

Advertisement

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Association of Clopidogrel Treatment with Risk of Mortality and Cardiovascular Events Following MI in Patients With and Without Diabetes

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content